期刊文献+

异亮氨酸拉链结构对可溶性CD40L生物学活性的影响 被引量:2

Effect of Isoleucine Zipper Motif on the Biological Activity of Human Soluble CD40L
原文传递
导出
摘要 CD40配基(CD40L)为TNF超家族中的一员,瞬时表达于激活的CD4+的T淋巴细胞上.自然状态下膜上三聚体的CD40L通过和CD40受体(CD40R)结合,在免疫监视和肿瘤免疫中发挥作用.以PCR方法从pcDNA3 CD40L质粒上扩增得到编码CD40L基因的胞外部分sCD40L,并将该片段插入大肠杆菌表达质粒pET30a上,构建得到大肠杆菌表达质粒pET30a sCD40L;同时,在sCD40L的N端融合了异亮氨酸拉链(IsoleucineZipper,IZ)结构,构建得到表达质粒pET30a IZ sCD40L.表达质粒在大肠杆菌中表达,得到可溶性的重组人CD40L和IZ CD40L.SDS PAGE分析结果表明重组人rhsCD40L和IZ rhsCD40L在相应分子质量位置都有明显的条带产生,并得到Westernblotting的确认.非SDS PAGE电泳结果显示,异亮氨酸拉链结构有利于rhsCD40L蛋白形成聚合体结构.B细胞增殖实验和人骨髓瘤细胞株XG2凋亡实验结果都表明,异亮氨酸拉链结构提高了rhsCD40L的生物学活性. CD40 Ligand (CD40L), a member of TNF superfamily, is expressed transiently on the surface of CD4+ T cells upon activation. It exists as a membraneanchored trimer. The interaction of CD40L with its receptor, CD40, plays a pivotal role in the immune surveillance and antitumor immunity. In this study, the extracellular domain of human CD40 (sCD40L, Tyr45 to Leu261) was expressed in expression vector pET30a with or without addition of an isoleucine zipper at the Nterminus. The constructs were introduced into E coli BL21 (DE3) strain for expression. The corresponding recombinant proteins, rhsCD40L and IZrhsCD40L, were purified by Ni2+chealating chromatography, and confirmed by SDSPAGE analysis followed by Western blotting. The fusion protein IZrhsCD40L showed a higher percentage of trimeric formation than rhsCD40L as revealed by NonSDSPAGE analysis. The biological activity of IZrhsCD40L was increased by 10fold compared with that of rhsCD40L on proliferation of B cells and apoptosis of XG2 cell line.
出处 《复旦学报(自然科学版)》 CAS CSCD 北大核心 2003年第4期564-569,575,共7页 Journal of Fudan University:Natural Science
关键词 可溶性CD40L 异亮氨酸拉链结构 表达 生物学活性 soluble CD40L isoleucine zipper motif expression biological function
  • 相关文献

参考文献16

  • 1萨母布鲁克J 弗里奇E F 曼尼阿蒂斯 T 金冬雁 黎孟枫译.分子克隆实验指南:第2版[M].北京:科学出版社,1998..
  • 2Graf D, Korthauer U, Mages H W, et al. Cloning of TRAP, a ligand for CD40 on human T cells [J]. Eur J Immunol, 1992, 22:3191-3194.
  • 3Renshaw B R, Fanslow W C, Armitage R J, et al. Humoral immune responses in CD40 ligand-deficient mice[J]. J Exp Med, 1994, 1080:1889-1900.
  • 4Funakoshi S, Longo D L, Beckwith M, et al. Inhibition of human B-cell lymphoma growth by CD40 stimulation [J]. Blood, 1994, 83:2787-2794.
  • 5Grewal I S, Flavell R A. CD40 and CD154 in cell-mediated immunity [J]. Annu Rev Immunol, 1998, 16:111-135.
  • 6Brossart P, Grunebach F, Stubler G, et al. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of GM-CSF [J]. Blood, 1998, 92: 4328-4247.
  • 7Armitage R J, Fanslow W C, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40 [J]. Nature, 1992, 357: 80-82.
  • 8Peitsch M C, Jongeneel C V. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors [J]. Int Immunol, 1993, 5: 233-238.
  • 9Landschulz W H, Johnson P F, Mckkninght S L, et al. The leucine zipper: A hypothetical structure common to a new DNA binding protein [J]. Science, 1988, 240: 1759-1764.
  • 10Fanslow W C, Srinivasan S, Paxton R, et al. Structural characteristics of CD40 ligand that determines biological function [J]. Semin Immunol, 1994, 6: 267-278.

同被引文献27

  • 1刘微,任汉云.人源化CD25单克隆抗体对外周血T淋巴细胞活化和增殖的影响[J].中国实验血液学杂志,2007,15(1):134-137. 被引量:1
  • 2吴剑卿,赵卫红,殷凯生,程蕴琳.腺相关病毒-CD40配体转导入肺癌细胞[J].中华肿瘤杂志,2007,29(4):253-257. 被引量:2
  • 3Quarrier P, Sanal O, Bustamante J, etal. Clinical, immunologic and genetic analysis of 29 patients with auto.real recessive hyper-IgM syn-drorne due to activation induced cytidine deaminase deficiency[J]. Clinical Immunology, 2004,110 (1) : 22.
  • 4Loskog A, Totterman TH. CD40 L-a multipotent molecule for tumor therapy[J]. Endocr Metab Immune Disord Drug Targets, 2007, 7(1):23.
  • 5Cignetti A, Vallario A, Follenzi A, et al. Lentiviral transduction of primary myeloma cells with CD80 and CD154 generates antimyeloma effector T cells [J]. Hum Gene Ther, 205, 16(4):445.
  • 6Delmas Y, Viallard JF, Villeneuve J, et al. Platelet-associated CD154:a new interface in haemostasis and in the inflammatory reaction [J]. Med Sci (Paris), 2005, 21 (10) : 825.
  • 7Lee SP, Ataga KI, Orringer EP, et al. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation[J]. Arterioscler Thromb Vasc Biol, 2006, 26(7) : 1415.
  • 8Sehemthaner GH, Kopp HP, Kezyzanowska K, et al. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery[J]. Eur J Clin Invest, 2006, 36(6) : 395.
  • 9Huang HI, Wu PY, Teo CY, et al. Improved immunogenicity of a self tumorantigen by covalent linkage to CD40 ligand [J]. Int J Cancer, 2004, 108(5):696.
  • 10Cusi MG, Del Veccbio MT, Terrosi C, et al. Immune-reconstituted influenzavirosome containing CD40 L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer Vaccine[J]. Immunol, 2005,174(11) : 7210.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部